Traws Pharma, Inc. (TRAW) Dividend History

Traws Pharma, Inc. (TRAW) is a biotechnology company focusing on the development of innovative pharmaceutical products. The company is dedicated to researching and bringing to market therapies aimed at addressing unmet medical needs, with a particular emphasis on novel formulations and delivery systems. Traws Pharma aims to leverage cutting-edge science to improve patient outcomes across various therapeutic areas.

12 Penns Trail, Newtown, PA, 18940
Phone: 267-759-3680
Website: https://www.onconova.com

Dividend History

Traws Pharma, Inc. currently does not pay dividends

Company News

  • Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

    Traws Pharma, a clinical-stage biopharmaceutical company, is developing novel antiviral therapies targeting respiratory viral diseases like bird flu, seasonal influenza, and COVID-19. The company submitted a Phase 2 protocol for tivoxavir marboxil and briefing documents to the FDA for a Type D meeting.

    GlobeNewswire Inc.
  • Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates

    Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 75% and 6.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: HRTX
  • Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket

    Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares. Flora Growth shares tumbled 20.2% to $2.13 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers HWH International Inc. (NASDAQ: HWH) rose 175% to $4.32 in pre-market trading. Zhongchao Inc. (NASDAQ: ZCMD) gained 43% to $2.18 in pre-market trading after gaining 22% on Wednesday. Brooge Energy Limited (NASDAQ: BROG) gained 26.4% to $2.39 in pre-market trading after dipping over 20% on Wednesday. Sintx Technologies, Inc. (NASDAQ: SINT) shares rose 23.5% to $0.0284 in pre-market trading. SiNtx Technologies shares fell around 45% on Wednesday after the company announced pricing of a $1.5 million public offering of common stock. Addex Therapeutics Ltd (NASDAQ: ADXN) shares rose 15.1% to $17.84 in pre-market trading. Addex Therapeutics shares gained 18% on Wednesday after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix.. Destiny Tech100 Inc. (NASDAQ: DXYZ) shares ...

    Benzinga
    Featured Companies: BROG DXYZ FLGC HWH LEVI ONMD RELI SINT SLP SRM VVPR XTIA ZCMD
Page data last updated 08/19/2025 16:43:55 UTC